# Epoetin beta

## Recormon inj 2000IU(限洗腎室用)

| TAH Drug Code      | [IRECB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IRECB)                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of symptomatic anemia in patients with chronic renal failure. Treatment of symptomatic anemia associated with cancer chemotherapy. Treatment of symptomatic anemia in adult patients undergoing anti-tumor therapy for multiple myeloma, low-grade non-Hodgkin’s lymphoma, or chronic lymphocytic leukemia.                                                                                                                                                                                |
| Dosing             | Anaemia with CRF: (Initially)SC, 3 x 20 IU/kg/week , if the increase of hemoglobin level is inadequate (<0.25g/dL per week), may be increased every 4 week by 3 x 20 IU/kg/week; IV, 3 x 40 IU/kg, may up to 80 IU/kg after 4 weeks, 3 times a week. (Maintenance) Half of initial dose, depend on individuals. Symptomatic anemia in patients with tumors/Multiple myeloma/Low grade non-Hodgkin’s lymphoma/Chronic lymphocytic leukemia: Initial dose of 450 IU/kg/week, may up to 900 IU/kg/week. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Erythropoiesis-stimulating agents should not be used in patients receiving myelosuppressive therapy when the expected outcome is curative. For anemia caused by chronic renal failure, it should not be used in infants (i.e., children under 2 years of age). Patients with known hypersensitivity to the active ingredient or any excipient of this product. Patients with uncontrolled hypertension.                                                                                              |
| Adverse Effects    | Increased BP, increased platelet count, encephalopathy-like symptoms, thromboembolic event, rash, pruritus, urticaria or inj site reactions.                                                                                                                                                                                                                                                                                                                                                         |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/methoxy-polyethylene-glycol-epoetin-beta-drug-information)                                                                                                                                                                                                                                                                                                                                                                                              |

